Literature DB >> 9648061

Obstructive nephropathy in the neonatal rat is attenuated by epidermal growth factor.

R L Chevalier1, S Goyal, J T Wolstenholme, B A Thornhill.   

Abstract

BACKGROUND: Obstructive nephropathy is a primary cause of renal failure in infancy. Chronic unilateral ureteral obstruction (UUO) in the neonatal rat results in reduced renal expression of epidermal growth factor (EGF), renal tubular epithelial (RTE) cell apoptosis and interstitial fibrosis. We wished to determine whether these changes could be prevented by exogenous administration of EGF.
METHODS: Thirty-three Sprague-Dawley rats underwent UUO within the first 48 hours of life, and received daily injections of either EGF (0.1 mg/kg/day) or saline (control) for the following seven days, after which obstructed and intact opposite kidneys were removed for study. These were compared to 11 sham-operated rats that received either no injections, EGF injections, or saline injections. Renal cell proliferation was determined by proliferating cell nuclear antigen, apoptosis was measured by the TUNEL technique, and the distribution of vimentin, clusterin, transforming growth factor-beta 1 (TGF-beta 1), and alpha-smooth muscle actin were determined by immunohistochemistry. Tubular dilation, tubular atrophy, and interstitial collagen deposition were quantitated by histomorphometry.
RESULTS: Compared to controls, EGF treatment increased RTE cell proliferation in the obstructed kidney by 76%, decreased apoptosis by 80%, and reduced vimentin, clusterin and TGF-beta 1 immunostaining (all P < 0.05). EGF treatment reduced tubular dilation by 50%, atrophic tubules by 30%, and interstitial fibrosis by 50% (all P < 0.05). There was no significant effect of EGF on renal alpha smooth muscle actin distribution. There was no effect of saline or EGF injections on kidneys from sham-operated rats for any of the parameters studied.
CONCLUSIONS: We conclude that EGF stimulates RTE cell proliferation and maturation and reduces apoptosis in the neonatal rat kidney subjected to chronic UUO. These effects may contribute to the reduction in tubular dilation, tubular atrophy, and interstitial fibrosis. By preserving renal development, administration of EGF attenuates the renal injury resulting from chronic UUO.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9648061     DOI: 10.1046/j.1523-1755.1998.00966.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  15 in total

1.  Heparin-binding EGF-like growth factor is up-regulated in the obstructed kidney in a cell- and region-specific manner and acts to inhibit apoptosis.

Authors:  H T Nguyen; S H Bride; A B Badawy; R M Adam; J Lin; A Orsola; P D Guthrie; M R Freeman; C A Peters
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

Review 2.  Congenital ureteropelvic junction obstruction: human disease and animal models.

Authors:  Julie Klein; Julien Gonzalez; Mathieu Miravete; Cécile Caubet; Rana Chaaya; Stéphane Decramer; Flavio Bandin; Jean-Loup Bascands; Bénédicte Buffin-Meyer; Joost P Schanstra
Journal:  Int J Exp Pathol       Date:  2010-07-30       Impact factor: 1.925

3.  Epidermal growth factor inhibits transforming growth factor-β-induced fibrogenic differentiation marker expression through ERK activation.

Authors:  Xiaoying Liu; Susan C Hubchak; James A Browne; H William Schnaper
Journal:  Cell Signal       Date:  2014-06-03       Impact factor: 4.315

4.  Longitudinal patterns of urine biomarkers in infants across gestational ages.

Authors:  Marissa J DeFreitas; Wacharee Seeherunvong; Chryso P Katsoufis; Satish RamachandraRao; Shahnaz Duara; Salih Yasin; Gaston Zilleruelo; Maria M Rodriguez; Carolyn L Abitbol
Journal:  Pediatr Nephrol       Date:  2016-02-09       Impact factor: 3.714

5.  Posterior urethral valve in fetuses: evidence for the role of inflammatory molecules.

Authors:  Érica Leandro Marciano Vieira; Natalia Pessoa Rocha; Fernando Macedo Bastos; Kátia Daniela da Silveira; Alamanda K Pereira; Eduardo Araújo Oliveira; Débora Marques de Miranda; Ana Cristina Simões E Silva
Journal:  Pediatr Nephrol       Date:  2017-02-22       Impact factor: 3.714

6.  Potential biological role of transforming growth factor-beta1 in human congenital kidney malformations.

Authors:  S P Yang; A S Woolf; H T Yuan; R J Scott; R A Risdon; M J O'Hare; P J Winyard
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

Review 7.  The proximal tubule is the primary target of injury and progression of kidney disease: role of the glomerulotubular junction.

Authors:  Robert L Chevalier
Journal:  Am J Physiol Renal Physiol       Date:  2016-05-18

8.  Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice.

Authors:  R J Fern; C M Yesko; B A Thornhill; H S Kim; O Smithies; R L Chevalier
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

9.  The effects of ACE inhibitor and angiotensin receptor blocker on clusterin and apoptosis in the kidney tissue of streptozotocin-diabetic rats.

Authors:  Matem Tunçdemir; Melek Ozturk
Journal:  J Mol Histol       Date:  2008-10-24       Impact factor: 2.611

10.  Protective Effect of Wharton's Jelly-derived Mesenchymal Stem Cells on Renal Fibrosis in Rats with Unilateral Ureteral Obstruction.

Authors:  Alireza Kheradmand; Mahmood Hashemitabar; Parvin Kheradmand; Farzin Valizadeh; Aryan Kavosh
Journal:  Eur Urol Open Sci       Date:  2020-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.